Literature DB >> 9039864

The art of 'HAART': researchers probe the potential and limits of aggressive HIV treatments.

J Stephenson.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9039864

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology.

Authors:  Yuqi Zhao; Min Yu; Johann W Miller; Mingzhong Chen; Eric G Bremer; William Kabat; Ram Yogev
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.

Authors:  Peter K Quashie; Maureen Oliviera; Tamar Veres; Nathan Osman; Ying-Shan Han; Said Hassounah; Yolanda Lie; Wei Huang; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

3.  A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF.

Authors:  Ravikiran S Yedidi; Gheorghe Proteasa; Philip D Martin; Zhigang Liu; John F Vickrey; Iulia A Kovari; Ladislau C Kovari
Journal:  J Mol Graph Model       Date:  2014-07-04       Impact factor: 2.518

4.  Data mining using template-based molecular docking on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1RT inhibitors.

Authors:  Nitin S Sapre; Swagata Gupta; Nilanjana Pancholi; Neelima Sapre
Journal:  J Mol Model       Date:  2008-07-19       Impact factor: 1.810

5.  Ocular manifestations in 321 male consecutive cases of human immunodeficiency virus infection/acquired immunodeficiency syndrome at an HIV-referral centre.

Authors:  Vikas Ambiya; Amitabh Sagar; Sagarika Patyal; A P Mohanty
Journal:  Med J Armed Forces India       Date:  2012-05-31

Review 6.  Biodegradable intraocular therapies for retinal disorders: progress to date.

Authors:  Noriyuki Kuno; Shinobu Fujii
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.